89bio Inc (ETNB)
9.02
+0.07
(+0.78%)
USD |
NASDAQ |
May 22, 10:48
89bio Accounts Payable (Quarterly): 15.35M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.35M |
December 31, 2023 | 8.585M |
September 30, 2023 | 10.90M |
June 30, 2023 | 10.72M |
March 31, 2023 | 16.73M |
December 31, 2022 | 12.50M |
September 30, 2022 | 14.15M |
June 30, 2022 | 4.907M |
March 31, 2022 | 4.421M |
December 31, 2021 | 6.843M |
September 30, 2021 | 12.53M |
Date | Value |
---|---|
June 30, 2021 | 1.915M |
March 31, 2021 | 4.521M |
December 31, 2020 | 2.065M |
September 30, 2020 | 4.086M |
June 30, 2020 | 3.07M |
March 31, 2020 | 4.055M |
December 31, 2019 | 0.989M |
September 30, 2019 | 3.571M |
June 30, 2019 | 0.968M |
December 31, 2018 | 1.509M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.968M
Minimum
Jun 2019
16.73M
Maximum
Mar 2023
7.144M
Average
4.714M
Median
Accounts Payable (Quarterly) Benchmarks
Akero Therapeutics Inc | 13.78M |
Madrigal Pharmaceuticals Inc | 21.53M |
Viking Therapeutics Inc | 5.225M |
Galectin Therapeutics Inc | 3.797M |
Terns Pharmaceuticals Inc | 1.701M |